The Brazilian government announced Wednesday it was negotiating the purchase of 30 million coronavirus vaccine doses from Russia and India, after regulators made it easier for the treatments to win emergency-use authorizations.
Until now, only the AstraZeneca/Oxford shot and China’s CoronaVac have been permitted in Brazil, the second-hardest-hit country after the US, with more than 226,000 deaths from COVID-19.
Brazil’s health surveillance agency said it would no longer require final Phase 3 trials to be carried out in Brazil, clearing the way for the emergency authorization of the vaccinations.
The health ministry said it is meeting from representatives from Russia and India on Friday to finalize details of a deal, which would see some 18 million doses delivered this month, and 12 million more in March.Read:Study finds fragmented sleep patterns can predict vulnerability to chronic stress
The move comes after The Lancet medical journal this week published results showing Sputnik V—named after the Soviet-era satellite—to be safe and 91.6 percent effective, allaying concerns over transparency.
Brazil began vaccinations January 17, starting with medical workers, the indigenous population and the elderly.
With 212 million inhabitants, Brazil has suffered an average of 1,062 deaths and 50,000 cases per day in the past week.
Follow the latest news on the coronavirus (COVID-19) outbreakRead:Israel extends nationwide coronavirus lockdown
© 2021 AFP
Brazil aims to buy 30 mn Sputnik V, Covaxin shots (2021, February 4)
retrieved 4 February 2021
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.